Improving Hypertension Control and Patient Engagement Using Digital Tools

American Journal of Medicine

Volumn 130, Issue 1, 2017, Pages 14-20

  Milani, Richard V ^a   Lavie, Carl J ^a   Bober, Robert M ^a   Milani, Alexander R ^a   Ventura, Hector O ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Chronic disease; Hypertension; Patient engagement

Indexed keywords

ANTIHYPERTENSIVE AGENT; CREATININE; THYROTROPIN;

AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE CONTROL; ELECTRONIC MEDICAL RECORD; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MEDICATION COMPLIANCE; PHYSICAL INACTIVITY; PRIORITY JOURNAL; PROGRAM EFFECTIVENESS; PULSE PRESSURE; SODIUM INTAKE; SYSTOLIC BLOOD PRESSURE; TELEMONITORING; THYROTROPIN BLOOD LEVEL; BLOOD PRESSURE; CLINICAL TRIAL; DEVICES; PATIENT PARTICIPATION; PROCEDURES; TELEMEDICINE;

AGED; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; FEMALE; HUMANS; HYPERTENSION; MALE; PATIENT PARTICIPATION; TELEMEDICINE;

EID: 85000692617     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2016.07.029     Document Type: Article

References (20)

1. 1 Lim, S.S., Vos, T., Flaxman, A.D., et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380 (2012), 2224–2260.
2. 2 Gaziano, T.A., Bitton, A., Anand, S., Weinstein, M.C., International Society of Hypertension. The global cost of nonoptimal blood pressure. J Hypertens 27:7 (2009), 1472–1477.
3. 3 Magid, D.J., Green, B.B., Home blood pressure monitoring: take it to the bank. JAMA 310 (2013), 40–41.
4. 4 Mozaffarian, D., Benjamin, E.J., Go, A.S., et al. Heart disease and stroke statistics-2016 update: A report from the American Heart Association. Circulation 133:4 (2016), e38–e360.
5. 5 Milani, R.V., Lavie, C.J., Healthcare 2020: reengineering healthcare delivery to combat chronic disease. Am J Med 128 (2015), 337–343.
6. 6 Glynn, L.G., Murphy, A.W., Smith, S.M., Schroeder, K., Fahey, T., Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database Syst Rev(3), 2010, CD005182.
7. 7 Pickering, T.G., Miller, N.H., Ogedegbe, G., et al. Call to action on use and reimbursement for home blood pressure monitoring: executive summary: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension 52 (2008), 1–9.
8. 8 Hibbard, J.H., Greene, J., What the evidence shows about patient activation: better health outcomes and care experiences; fewer data on costs. Health Aff (Millwood) 32:2 (2013), 207–214.
9. 9 McNamara, K.P., Versace, V.L., Marriott, J.L., Dunbar, J.A., Patient engagement strategies used for hypertension and their influence on self-management attributes. Fam Pract 31 (2014), 437–444.
10. 10 Margolis, K.L., Asche, S.E., Bergdall, A.R., et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA 310 (2013), 46–56.
11. 11 Milani, R.V., Bober, R.M., Lavie, C.J., The role of technology in chronic disease care. Prog Cardiovasc Dis 58:6 (2016), 579–583.
12. 12 Chobanian, A.V., Bakris, G.L., Black, H.R., et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289 (2003), 2560–2572.
13. 13 James, P.A., Oparil, S., Carter, B.L., et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311:5 (2014), 507–520.
14. 14 Egan, B.M., Zhao, Y., Axon, R.N., US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA 303 (2010), 2043–2050.
15. 15 Kung, H.C., Xu, J., Hypertension-related mortality in the United States, 2000-2013. NCHS Data Brief(193), 2015, 1–8.
16. 16 Okonofua, E.C., Simpson, K.N., Jesri, A., Rehman, S.U., Durkalski, V.L., Egan, B.M., Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals. Hypertension 47 (2006), 345–351.
17. 17 Xu, W., Goldberg, S.I., Shubina, M., Turchin, A., Optimal systolic blood pressure target, time to intensification, and time to follow-up in treatment of hypertension: population based retrospective cohort study. BMJ, 350, 2015, h158.
18. 18 Hibbard, J.H., Greene, J., Overton, V., Patients with lower activation associated with higher costs; delivery systems should know their patients' ‘scores’. Health Aff (Millwood) 32:2 (2013), 216–222.
19. 19 Greene, J., Hibbard, J.H., Sacks, R., Overton, V., Parrotta, C.D., When patient activation levels change, health outcomes and costs change, too. Health Aff (Millwood) 34:3 (2015), 431–437.
20. 20 Christakis, N.A., Fowler, J.H., Social contagion theory: examining dynamic social networks and human behavior. Stat Med 32:4 (2013), 556–577.